EMEA (Europe, Middle East and Africa) Hereditary Angioedema Drug Market Report 2017

October 2017 | 101 pages | ID: EE7A92F896APEN
QYResearch

Abstracts

In this report, the EMEA Hereditary Angioedema Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Hereditary Angioedema Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Hereditary Angioedema Drug market competition by top manufacturers/players, with Hereditary Angioedema Drug sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pharming Group NV
• Shire plc
• CSL Limited
• iBio Inc.
• BioCryst Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

• By Product
• C1 Esterase Inhibitor
• Kallikrein Inhibitor
• Selective Bradykinin B2 Receptor Antagonist
• By Route of Administration
• Oral
• Intravenous
• Subcutaneous Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Hereditary Angioedema Drug for each application, including

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Hereditary Angioedema Drug Market Report 2017

1 HEREDITARY ANGIOEDEMA DRUG OVERVIEW

1.1 Product Overview and Scope of Hereditary Angioedema Drug
1.2 Classification of Hereditary Angioedema Drug
  1.2.1 EMEA Hereditary Angioedema Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Hereditary Angioedema Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 C1 Esterase Inhibitor
  1.2.4 Kallikrein Inhibitor
  1.2.5 Selective Bradykinin B2 Receptor Antagonist
1.3 EMEA Hereditary Angioedema Drug Market by Application/End Users
  1.3.1 EMEA Hereditary Angioedema Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Retail Pharmacies
  1.3.3 Hospital Pharmacies
  1.3.4 Online Pharmacies
1.4 EMEA Hereditary Angioedema Drug Market by Region
  1.4.1 EMEA Hereditary Angioedema Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Hereditary Angioedema Drug (2012-2022)
  1.5.1 EMEA Hereditary Angioedema Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Hereditary Angioedema Drug Revenue and Growth Rate (2012-2022)

2 EMEA HEREDITARY ANGIOEDEMA DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Hereditary Angioedema Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Hereditary Angioedema Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Hereditary Angioedema Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Hereditary Angioedema Drug Sale Price by Players (2012-2017)
2.2 EMEA Hereditary Angioedema Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Hereditary Angioedema Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Hereditary Angioedema Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Hereditary Angioedema Drug Sale Price by Type (2012-2017)
2.3 EMEA Hereditary Angioedema Drug (Volume) by Application
2.4 EMEA Hereditary Angioedema Drug (Volume and Value) by Region
  2.4.1 EMEA Hereditary Angioedema Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Hereditary Angioedema Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Hereditary Angioedema Drug Sales Price by Region (2012-2017)

3 EUROPE HEREDITARY ANGIOEDEMA DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Hereditary Angioedema Drug Sales and Value (2012-2017)
  3.1.1 Europe Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Hereditary Angioedema Drug Sales and Market Share by Type
3.3 Europe Hereditary Angioedema Drug Sales and Market Share by Application
3.4 Europe Hereditary Angioedema Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Hereditary Angioedema Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Hereditary Angioedema Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST HEREDITARY ANGIOEDEMA DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Hereditary Angioedema Drug Sales and Value (2012-2017)
  4.1.1 Middle East Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Hereditary Angioedema Drug Sales and Market Share by Type
4.3 Middle East Hereditary Angioedema Drug Sales and Market Share by Application
4.4 Middle East Hereditary Angioedema Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Hereditary Angioedema Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Hereditary Angioedema Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)

5 AFRICA HEREDITARY ANGIOEDEMA DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Hereditary Angioedema Drug Sales and Value (2012-2017)
  5.1.1 Africa Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Hereditary Angioedema Drug Sales and Market Share by Type
5.3 Africa Hereditary Angioedema Drug Sales and Market Share by Application
5.4 Africa Hereditary Angioedema Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Hereditary Angioedema Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Hereditary Angioedema Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)

6 EMEA HEREDITARY ANGIOEDEMA DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pharming Group NV
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hereditary Angioedema Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Shire plc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Hereditary Angioedema Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Shire plc Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CSL Limited
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Hereditary Angioedema Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 iBio Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Hereditary Angioedema Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 iBio Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 BioCryst Pharmaceuticals, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Hereditary Angioedema Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Ionis Pharmaceuticals, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Hereditary Angioedema Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 HEREDITARY ANGIOEDEMA DRUG MANUFACTURING COST ANALYSIS

7.1 Hereditary Angioedema Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hereditary Angioedema Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hereditary Angioedema Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hereditary Angioedema Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HEREDITARY ANGIOEDEMA DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Hereditary Angioedema Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Hereditary Angioedema Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Hereditary Angioedema Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Hereditary Angioedema Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Hereditary Angioedema Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Hereditary Angioedema Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Hereditary Angioedema Drug
Figure EMEA Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2022)
Figure EMEA Hereditary Angioedema Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure C1 Esterase Inhibitor Product Picture
Figure Kallikrein Inhibitor Product Picture
Figure Selective Bradykinin B2 Receptor Antagonist Product Picture
Figure EMEA Hereditary Angioedema Drug Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Hereditary Angioedema Drug by Application in 2016
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure EMEA Hereditary Angioedema Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hereditary Angioedema Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Hereditary Angioedema Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Hereditary Angioedema Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Hereditary Angioedema Drug Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Hereditary Angioedema Drug Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Hereditary Angioedema Drug Sales Share by Players (2012-2017)
Figure 2016 Hereditary Angioedema Drug Sales Share by Players
Figure 2017 Hereditary Angioedema Drug Sales Share by Players
Figure EMEA Hereditary Angioedema Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Hereditary Angioedema Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Hereditary Angioedema Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Hereditary Angioedema Drug Revenue Share by Players
Table 2017 EMEA Hereditary Angioedema Drug Revenue Share by Players
Table EMEA Hereditary Angioedema Drug Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Hereditary Angioedema Drug Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Hereditary Angioedema Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Hereditary Angioedema Drug by Type (2012-2017)
Figure EMEA Hereditary Angioedema Drug Sales Market Share by Type (2012-2017)
Table EMEA Hereditary Angioedema Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Hereditary Angioedema Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hereditary Angioedema Drug by Type in 2016
Table EMEA Hereditary Angioedema Drug Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Hereditary Angioedema Drug Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Hereditary Angioedema Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Hereditary Angioedema Drug by Application (2012-2017)
Figure EMEA Hereditary Angioedema Drug Sales Market Share by Application in 2016
Table EMEA Hereditary Angioedema Drug Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Hereditary Angioedema Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Hereditary Angioedema Drug by Region (2012-2017)
Figure EMEA Hereditary Angioedema Drug Sales Market Share in 2016
Table EMEA Hereditary Angioedema Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Hereditary Angioedema Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Hereditary Angioedema Drug by Region (2012-2017)
Figure EMEA Hereditary Angioedema Drug Revenue Market Share Regions in 2016
Table EMEA Hereditary Angioedema Drug Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Europe Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
Table Europe Hereditary Angioedema Drug Sales (MT) by Type (2012-2017)
Table Europe Hereditary Angioedema Drug Market Share by Type (2012-2017)
Figure Europe Hereditary Angioedema Drug Market Share by Type in 2016
Table Europe Hereditary Angioedema Drug Sales (MT) by Application (2012-2017)
Table Europe Hereditary Angioedema Drug Market Share by Application (2012-2017)
Figure Europe Hereditary Angioedema Drug Market Share by Application in 2016
Table Europe Hereditary Angioedema Drug Sales (MT) by Countries (2012-2017)
Table Europe Hereditary Angioedema Drug Sales Market Share by Countries (2012-2017)
Figure Europe Hereditary Angioedema Drug Sales Market Share by Countries (2012-2017)
Figure Europe Hereditary Angioedema Drug Sales Market Share by Countries in 2016
Table Europe Hereditary Angioedema Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Hereditary Angioedema Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Hereditary Angioedema Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Hereditary Angioedema Drug Revenue Market Share by Countries in 2016
Figure Germany Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure France Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure UK Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Russia Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Italy Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Hereditary Angioedema Drug Sales (MT) by Type (2012-2017)
Table Middle East Hereditary Angioedema Drug Market Share by Type (2012-2017)
Figure Middle East Hereditary Angioedema Drug Market Share by Type (2012-2017)
Table Middle East Hereditary Angioedema Drug Sales (MT) by Applications (2012-2017)
Table Middle East Hereditary Angioedema Drug Market Share by Applications (2012-2017)
Figure Middle East Hereditary Angioedema Drug Sales Market Share by Application in 2016
Table Middle East Hereditary Angioedema Drug Sales Volume (MT) by Countries (2012-2017)
Table Middle East Hereditary Angioedema Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Hereditary Angioedema Drug Sales Volume Market Share by Countries in 2016
Table Middle East Hereditary Angioedema Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Hereditary Angioedema Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Hereditary Angioedema Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Hereditary Angioedema Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Israel Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure UAE Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Iran Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Africa Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Africa Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Hereditary Angioedema Drug Sales (MT) by Type (2012-2017)
Table Africa Hereditary Angioedema Drug Sales Market Share by Type (2012-2017)
Figure Africa Hereditary Angioedema Drug Sales Market Share by Type (2012-2017)
Figure Africa Hereditary Angioedema Drug Sales Market Share by Type in 2016
Table Africa Hereditary Angioedema Drug Sales (MT) by Application (2012-2017)
Table Africa Hereditary Angioedema Drug Sales Market Share by Application (2012-2017)
Figure Africa Hereditary Angioedema Drug Sales Market Share by Application (2012-2017)
Table Africa Hereditary Angioedema Drug Sales Volume (MT) by Countries (2012-2017)
Table Africa Hereditary Angioedema Drug Sales Market Share by Countries (2012-2017)
Figure Africa Hereditary Angioedema Drug Sales Market Share by Countries (2012-2017)
Figure Africa Hereditary Angioedema Drug Sales Market Share by Countries in 2016
Table Africa Hereditary Angioedema Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Hereditary Angioedema Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Hereditary Angioedema Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Hereditary Angioedema Drug Revenue Market Share by Countries in 2016
Figure South Africa Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Table Pharming Group NV Hereditary Angioedema Drug Basic Information List
Table Pharming Group NV Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Sales Market Share in EMEA (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Revenue Market Share in EMEA (2012-2017)
Table Shire plc Hereditary Angioedema Drug Basic Information List
Table Shire plc Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Sales Market Share in EMEA (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Revenue Market Share in EMEA (2012-2017)
Table CSL Limited Hereditary Angioedema Drug Basic Information List
Table CSL Limited Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Sales Market Share in EMEA (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Revenue Market Share in EMEA (2012-2017)
Table iBio Inc. Hereditary Angioedema Drug Basic Information List
Table iBio Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Sales Market Share in EMEA (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Revenue Market Share in EMEA (2012-2017)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Basic Information List
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Market Share in EMEA (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share in EMEA (2012-2017)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Basic Information List
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Market Share in EMEA (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereditary Angioedema Drug
Figure Manufacturing Process Analysis of Hereditary Angioedema Drug
Figure Hereditary Angioedema Drug Industrial Chain Analysis
Table Raw Materials Sources of Hereditary Angioedema Drug Major Manufacturers in 2016
Table Major Buyers of Hereditary Angioedema Drug
Table Distributors/Traders List
Figure EMEA Hereditary Angioedema Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Hereditary Angioedema Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Hereditary Angioedema Drug Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Hereditary Angioedema Drug Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Hereditary Angioedema Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Hereditary Angioedema Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Hereditary Angioedema Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Hereditary Angioedema Drug Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Hereditary Angioedema Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Hereditary Angioedema Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Hereditary Angioedema Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Hereditary Angioedema Drug Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Hereditary Angioedema Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Hereditary Angioedema Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Hereditary Angioedema Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Hereditary Angioedema Drug Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Hereditary Angioedema Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Hereditary Angioedema Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Hereditary Angioedema Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Hereditary Angioedema Drug Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Hereditary Angioedema Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Hereditary Angioedema Drug Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Hereditary Angioedema Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources